MapLight Therapeutics, Inc.(MPLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MPLT MapLight Therapeutics, Inc.

Post-Mkt 07-31 17:17:33 EDT

13.02

-1.01

-7.20%

盘后12.50

-0.52-3.99%

17:02 EDT

High14.99	Low13.00	Vol1.15M
Open14.42	D1 Closing14.03	Amplitude14.18%
Mkt Cap590.40M	Tradable Cap142.92M	Total Shares45.35M
T/O15.59M	T/O Rate10.43%	Tradable Shares10.98M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MPLT","market":"US","secType":"STK","nameCN":"MapLight Therapeutics, Inc.","latestPrice":13.02,"timestamp":1785528000000,"preClose":14.03,"halted":0,"volume":1145093,"hourTrading":{"tag":"盘后","latestPrice":12.5,"preClose":13.02,"latestTime":"17:02 EDT","volume":4456,"amount":57297.660923999996,"timestamp":1785531776727,"change":-0.52,"changeRate":-0.039939,"amplitude":0.076805},"delay":0,"changeRate":-0.07198859586600141,"floatShares":10976700,"shares":45345700,"eps":-4.412,"marketStatus":"Post-Mkt","change":-1.01,"latestTime":"07-31 17:17:33 EDT","open":14.42,"high":14.99,"low":13,"amount":15591083.592172999,"amplitude":0.141839,"askPrice":12.85,"askSize":1240,"bidPrice":12.49,"bidSize":38,"shortable":0,"etf":0,"ttmEps":-4.412,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1785542400000},"marketStatusCode":4,"adr":0,"listingDate":1761537600000,"exchange":"NASDAQ","adjPreClose":14.03,"preHourTrading":{"tag":"盘前","latestPrice":14.05,"preClose":14.03,"latestTime":"09:28 EDT","volume":6035,"amount":87464.80841,"timestamp":1785504537997,"change":0.02,"changeRate":0.001426,"amplitude":0.063435},"postHourTrading":{"tag":"盘后","latestPrice":12.5,"preClose":13.02,"latestTime":"17:02 EDT","volume":4456,"amount":57297.660923999996,"timestamp":1785531776727,"change":-0.52,"changeRate":-0.039939,"amplitude":0.076805},"volumeRatio":0.27935,"impliedVol":1.2259,"impliedVolPercentile":0.1818},"requestUrl":"/m/hq/s/MPLT/wiki","defaultTab":"wiki","newsList":[{"id":"2655384282","title":"Catalyst4 Reports $13.84 Million MapLight Therapeutics Common Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2655384282","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655384282?lang=en_us&edition=fundamental","pubTime":"2026-07-31 06:40","pubTimestamp":1785451206,"startTime":"0","endTime":"0","summary":"Catalyst4 reports $13.84 million MapLight Therapeutics common share purchaseCatalyst4, a 10% owner of Maplight Therapeutics, reported open-market purchases totaling 1,209,225 voting common shares.Purc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDLfqNPZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Catalyst4 Reports $13.84 Million MapLight Therapeutics Common Share Purchase","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655801359","title":"MapLight Therapeutics, Inc. (MPLT) Gets a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2655801359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655801359?lang=en_us&edition=fundamental","pubTime":"2026-07-30 23:26","pubTimestamp":1785425177,"startTime":"0","endTime":"0","summary":"Jefferies analyst maintained a Buy rating on MapLight Therapeutics, Inc. today and set a price target of $25.00. In addition to Jefferies, MapLight...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maplight-therapeutics-inc-mplt-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maplight-therapeutics-inc-mplt-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655342048","title":"Maplight Therapeutics Director Troy Cox Reports Purchase of 15,620 Shares Worth $148,702.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2655342048","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655342048?lang=en_us&edition=fundamental","pubTime":"2026-07-29 09:15","pubTimestamp":1785287721,"startTime":"0","endTime":"0","summary":"Maplight Therapeutics director Troy Cox reports purchase of 15,620 shares worth $148,702.4Maplight Therapeutics director Troy Cox reported buying 15,620 shares of voting common stock at a weighted ave","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDLb1bBRH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Maplight Therapeutics Director Troy Cox Reports Purchase of 15,620 Shares Worth $148,702.4","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654500961","title":"MapLight Therapeutics price target lowered to $24 from $43 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2654500961","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654500961?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:20","pubTimestamp":1785237629,"startTime":"0","endTime":"0","summary":"Canaccord lowered the firm’s price target on MapLight Therapeutics (MPLT) to $24 from $43 and keeps a Buy rating on the shares. The firm updated it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-24-from-43-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-price-target-lowered-to-24-from-43-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006677","title":"MapLight downgraded to Equal Weight from Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006677","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006677?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:56","pubTimestamp":1785236218,"startTime":"0","endTime":"0","summary":"Morgan Stanley downgraded MapLight Therapeutics (MPLT) to Equal Weight from Overweight with a price target of $21, down from $34. While the ZEPHYR ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-downgraded-to-equal-weight-from-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-downgraded-to-equal-weight-from-overweight-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654058910","title":"MapLight Therapeutics is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2654058910","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654058910?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:28","pubTimestamp":1785234480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MPLT/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654071164","title":"U.S. Research Roundup- BioLife Solutions, Gossamer Bio, Intuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2654071164","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654071164?lang=en_us&edition=fundamental","pubTime":"2026-07-28 15:31","pubTimestamp":1785223918,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, IntuitJuly 28 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including BioL","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL4N43U0K0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDGF","BWFG","BLFS","NVTS","GOSS","GDX","LMTS","CIFR","CUT","IDU","HIG","HAPN","LMT","HRB","STCE","BRBR","SRCE","NEM","GTY","CHRW","IP","HCA","BY","CLSK","LW","OWL","GSHD","LMTL","CDNS","INTU","ENSG","FMBH","FFIV","BKR","HBT","NEE","OTIS","CBOE","PINE","DIPR","CHMG","HUT","FRPT","MPLT","AGYS","MSBI","RNWZ","HTH","PPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654078237","title":"Maplight Therapeutics Inc : Jefferies Cuts Target Price to $25 from $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2654078237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654078237?lang=en_us&edition=fundamental","pubTime":"2026-07-28 12:55","pubTimestamp":1785214549,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43U09I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654204494","title":"Analysts Are Bullish on Top NA Stocks: Syensqo SA/NV (SHBBF), MapLight Therapeutics, Inc. (MPLT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654204494","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654204494?lang=en_us&edition=fundamental","pubTime":"2026-07-28 01:00","pubTimestamp":1785171618,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Syensqo SA/NV (SHBBF) and MapLight Therapeutics, Inc. (MPLT)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-syensqo-sa-nv-shbbf-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-syensqo-sa-nv-shbbf-maplight-therapeutics-inc-mplt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654801068","title":"MapLight's Schizophrenia Drug Fails Once-daily Test, Shares Plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=2654801068","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654801068?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:27","pubTimestamp":1785155262,"startTime":"0","endTime":"0","summary":"MapLight's schizophrenia drug fails once-daily test, shares plungeJuly 27 (Reuters)-MapLight TherapeuticsMPLT.Osaid on Monday its schizophrenia drug failed to show statistically significant symptom im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL4N43T0VE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","LU1670710661.SGD","BK4559","LU0456855351.SGD","LU1032466523.USD","LU1718418525.SGD","LU0321505868.SGD","LU0306807586.USD","LU0882574055.USD","LU1093756168.USD","LU2125154935.USD","LU1670711040.USD","LU1571399168.USD","LU1093756325.SGD","LU1983299246.USD","LU1670710588.SGD","LU1323610961.USD","LU0868494617.USD","LU0306806265.USD","LU1261432733.SGD","IE00BFXG1179.USD","LU0096364046.USD","LU1585245621.USD","LU1291159041.SGD","LU2133065610.SGD","BMY","LU0061475181.USD","IE00B2B36J28.USD","LU1074936037.SGD","LU1868837136.USD","LU1868837300.USD","BK4007","LU1670711123.USD","LU2242646821.SGD","LU0432979614.USD","IE0009355771.USD","LU0225284248.USD","FTXH","MPLT","LU0267386448.USD","LU1430594728.SGD","LU2125154778.USD","BK4534","LU2360032135.SGD","IE00BJT1NW94.SGD","LU1868836591.USD","BK4588","IE00BFTCPJ56.SGD","LU1868836914.USD","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654017731","title":"Maplight Therapeutics Shares Drop 55.7% Premarket After Co Announces Mid-Stage Trial Results for Schizophrenia Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2654017731","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654017731?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:12","pubTimestamp":1785154348,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL4N43T0X6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654012194","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2654012194","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654012194?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:39","pubTimestamp":1785152371,"startTime":"0","endTime":"0","summary":"STAK  shares were down 55% in Monday premarket trading after the earlier session's 602% rally.MapLight Therapeutics  stock was down 55% after the company said a phase 2 trial of ML-007C-MA in schizophrenia met its primary endpoint, demonstrating a significant reduction in severity of the condition versus placebo.Profusa  shares were down 18% after the company signed a non-binding term sheet to acquire a privately held commercial-stage diagnostics and toxicology testing company.Recon Technology  stock was down 15%, following the earlier session's 11.6% gain.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4179","STAK","RCON","PFSA","MPLT","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654014028","title":"MapLight Therapeutics announces topline results from ZEPHYR trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2654014028","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654014028?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:16","pubTimestamp":1785150965,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics (MPLT) announced topline results from its Phase 2 ZEPHYR trial evaluating ML-007C-MA, an oral M1/M4 muscarinic agonist co-for...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-announces-topline-results-from-zephyr-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maplight-therapeutics-announces-topline-results-from-zephyr-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1989772923.USD","SG9999000418.SGD","XLF","LU2360107671.USD","LU1868837300.USD","LU1814569148.SGD","LU1861217088.USD","LU0198837287.USD","IPAY","LU0127658192.USD","LU1815333072.USD","LU2403377893.USD","LATR","LU1280957306.USD","SGXZ51526630.SGD","LU2764262908.HKD","STBQ","MPLT","LU0868494708.USD","LU1974910355.USD","LU1691799644.USD","BK4227","LU0109391861.USD","LU0642271901.SGD","IE00BN29S564.USD","LU0912757837.SGD","LU0061474705.USD","LU2237957811.SGD","LU2552382058.USD","LU2506951875.HKD","LU0170899867.USD","LU1629891620.HKD","SG9999011175.SGD","MA","LU0006306889.USD","FNCL","LU0950375773.USD","LU0234570918.USD","LU2023250504.SGD","LU0345769631.USD","IE000SO60NU8.SGD","FDFF","BK4534","VFH","IE00BHPRN162.USD","UYG","SG9999002232.USD","LU2361044865.SGD","IYG","LU0353189680.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654014558","title":"MapLight Says Phase 2 Zephyr Trial Shows Ml-007c-ma Cuts PANSS Score in Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2654014558","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654014558?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:02","pubTimestamp":1785150129,"startTime":"0","endTime":"0","summary":"MapLight says Phase 2 ZEPHYR trial shows ML-007C-MA cuts PANSS score in schizophreniaMapLight Therapeutics reported positive topline results from its Phase 2 ZEPHYR trial of ML-007C-MA in adults with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL3f19z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","BK4112","IE00B3QW5Z07.USD","NDAQ","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","SG9999014013.SGD","BCDF","BK4139","MPLT","IE00BKPKM429.USD","SG9999014039.USD","SG9999014021.USD","BK4585","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014005.SGD","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654143780","title":"Maplight Therapeutics - to Proceed with Additional Registrational Trial and Engage FDA at End-of-Phase 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2654143780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654143780?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA6GMRCS:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654142010","title":"Maplight Therapeutics Inc - 330/6 Mg Once-Daily (Qd) Dose Did not Achieve Statistical Significance on Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2654142010","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654142010?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA6GMRCS:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654014822","title":"Maplight Therapeutics Announces Positive Topline Results from Phase 2 Zephyr Trial of Ml-007C-Ma in Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2654014822","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654014822?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA6GMRCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654014373","title":"Maplight Therapeutics - Ml-007C-Ma Well Tolerated with no Serious or Drug-Related Severe Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2654014373","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654014373?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA6GMRCS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654014340","title":"Maplight Therapeutics - 210/3 Mg Bid Dose Shows Significant Panss Improvement at Week 5 in Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2654014340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654014340?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA6GMRCS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654601468","title":"MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2654601468","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654601468?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150000,"startTime":"0","endTime":"0","summary":"The trial, designed and sized to support registration, met its primary endpoint, with the 210/3 mg BID dose demonstrating a statistically significant improvement in PANSS total score compared to place","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/27/3333379/0/en/MapLight-Therapeutics-Announces-Positive-Topline-Results-from-Phase-2-ZEPHYR-Trial-of-ML-007C-MA-in-Schizophrenia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4JS1V06.HKD","LU0056508442.USD","XLF","LU2506951958.HKD","MA","LU1718418525.SGD","LU0557290698.USD","LU2168564149.EUR","LU0210533765.USD","LU2420271590.USD","LATR","LU0708995401.HKD","VFH","BID","LU1815333072.USD","IYG","LU0823421333.USD","STBQ","FDFF","LU2077746001.SGD","IPAY","LU0642271901.SGD","LU0107464264.USD","LU2092937148.SGD","IE000WAW04H5.SGD","LU0061475181.USD","LU2168563687.JPY","ASD","LU2092627202.USD","BK4585","MPLT","LU2360107671.USD","IE00BKDWB100.SGD","BK4533","LU1316542783.SGD","LU1732800096.USD","UYG","LU0823434583.USD","FNCL","LU0823417653.USD","LU0096362180.USD","LU1861217088.USD","LU1712237335.SGD","BK4139","BK4527","LU0823421416.USD","LU1868836914.USD","LU1983260115.SGD","SG9999003800.SGD","LU1280957306.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.maplightrx.com","stockEarnings":[{"period":"1week","weight":-0.6018},{"period":"1month","weight":-0.6085},{"period":"3month","weight":-0.543},{"period":"6month","weight":-0.2069},{"period":"1year","weight":-0.1747},{"period":"ytd","weight":-0.2013}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0292},{"period":"6month","weight":0.0719},{"period":"1year","weight":0.169},{"period":"ytd","weight":0.0876}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"MapLight Therapeutics, Inc.","nameEN":"MapLight Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MapLight Therapeutics, Inc.(MPLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MapLight Therapeutics, Inc.(MPLT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MapLight Therapeutics, Inc.,MPLT,MapLight Therapeutics, Inc.股票,MapLight Therapeutics, Inc.股票老虎,MapLight Therapeutics, Inc.股票老虎国际,MapLight Therapeutics, Inc.行情,MapLight Therapeutics, Inc.股票行情,MapLight Therapeutics, Inc.股价,MapLight Therapeutics, Inc.股市,MapLight Therapeutics, Inc.股票价格,MapLight Therapeutics, Inc.股票交易,MapLight Therapeutics, Inc.股票购买,MapLight Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MapLight Therapeutics, Inc.(MPLT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MapLight Therapeutics, Inc.(MPLT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}